课题基金 / 基金详情

Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression

Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression
确定治疗功效并揭示肿瘤抑制机制
批准号:
8787676
负责人:
David Feldser
金额:
$23.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-19 至 2016-01-31

项目摘要

项目成果

David Feldser的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract My research is focused on elucidating the cellular and molecular mechanisms that constrain malignant cancers. It is known that cells possess intrinsic and extrinsic tumor- suppressor mechanisms that are orchestrated by a handful of key tumor-suppressor genes. However, the inability to restore tumor suppressor function at will in established tumors has hampered our understanding of their functions. The project proposed within this K99/R00 award outlines the creation and implementation of novel mouse models that allow gene inactivation and gene restoration to be controlled in a tissue-specific and temporal manner. The research proposed within this application has been shaped by my experiences studying the consequences of telomere dysfunction in a model of Burkitt's lymphoma and by my recent efforts to elucidate the in vivo effects of restoring the p53 tumor-suppressor gene in several models of diverse human cancers. These research projects solidified my interests in pursuing a career studying the fundamental components of human cancer progression. My desire to interrogate the biology of tumor-suppression requires the development of novel genetic systems in which tumor-suppressor gene function can be inactivated and then subsequently restored. The systems that we propose herein utilize autochthonous mouse models and genetically defined human cancer cells. Comparative analysis of these systems will enhance discovery of fundamental mechanisms of tumor suppression by capitalizing on the relevant in vivo setting and the relevant organism in which to study human cancer. The facilities at the Koch Institute at MIT, and the expertise that my mentor, Dr. Jacks, can provide will be invaluable for successful implementation of this project. The goals of these experiments outlined within are: • to highlight the therapeutic potential of targeting these tumor-suppressor pathways as a means to eradicate cancer, • to identify relevant mechanisms by which tumor-suppressor genes inhibit cancer formation or progression in a variety of tumor types, • to uncover biological programs unleashed upon tumor-suppressor gene restoration, and • to identify specific novel targets for therapeutic intervention. The research environment in the Jacks Laboratory, MIT, and the surrounding area offers unmatched opportunities for scientific discussion, collaboration, and training. Currently, I supervise an undergraduate student and a technical assistant that work directly with me on experiments pertaining to my research. This is an incredible experience that will endow me with many of the necessary skills to manage an independent laboratory. The scientific community at MIT, the Broad Institute, and Harvard Medical School offers countless seminars and workshops that will continue to foster my scientific development. My immediate goals are to develop the research platform described in this application and to demonstrate its potential to unlock heretofore uncharacterized molecular and cellular mechanisms of tumor suppression. It is my intention to start an independent research program that will capitalize on these in vivo systems by studying multiple tumor-suppressor genes in a variety of important tumor types. For the long-term, I am confident that these experiments will provide a foundation on which my research program can grow. I look forward to educating and recruiting students and postdocs that share my passion for cancer research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein kinase C and lung carcinogenesis
  • 批准号:
    10733467
  • 项目类别:
  • 资助金额:
    $67.44万
  • 财政年份:
    2023
  • 负责人:
    David Feldser
  • 依托单位:
Identifying the Impact of SETD2 Inactivation in Lung Adenocarcinoma
  • 批准号:
    10539347
  • 项目类别:
  • 资助金额:
    $43.91万
  • 财政年份:
    2021
  • 负责人:
    David Feldser
  • 依托单位:
Identifying the Impact of SETD2 Inactivation in Lung Adenocarcinoma
  • 批准号:
    10366169
  • 项目类别:
  • 资助金额:
    $44.59万
  • 财政年份:
    2021
  • 负责人:
    David Feldser
  • 依托单位:
Deconstructing the multi-faceted roles of Rb in tumor progression
  • 批准号:
    9755390
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2018
  • 负责人:
    David Feldser
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: